Augustine Lawlor - Chief Operating Officer at Leap Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Operating Officer
Stock Symbol
LPTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Augustine Lawlor since 12/22/2023

Holdings reported by Augustine Lawlor for Leap Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 678K $1.91M $2.82 Nov 13, 2024 Indirect
Common Stock 5.09K $14.3K $2.82 Nov 13, 2024 Direct
Restricted Stock Units 0 $0 $2.85 Jan 26, 2024 Direct Common Stock
Employee Stock Option (Right to Buy) 85K Oct 2, 2024 Direct Common Stock
Employee Stock Option (Right to Buy) 85K Jan 29, 2024 Direct Common Stock
Warrant (Right to Buy) 0 Nov 13, 2024 Indirect Common Stock, $0.001 par value per share

Transactions reported by Augustine Lawlor for Leap Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.